Literature DB >> 8521023

Electrophysiological effects of azelastine in isolated guinea pig atrial and ventricular fibers.

V Kecskeméti1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8521023     DOI: 10.1007/bf01674415

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


× No keyword cloud information.
  8 in total

Review 1.  Classification of antidysrhythmic drugs.

Authors:  E M Vaughan Williams
Journal:  Pharmacol Ther B       Date:  1975

2.  Action of azelastine on intracellular Ca2+ in cultured airway smooth muscle.

Authors:  N Senn; E Jeanclos; R Garay
Journal:  Eur J Pharmacol       Date:  1991-11-19       Impact factor: 4.432

Review 3.  Azelastine: a multifaceted drug for asthma therapy.

Authors:  I Szelenyi; U Achterrath-Tuckermann; J Schmidt; E Minker; I Paegelow; H Werner
Journal:  Agents Actions Suppl       Date:  1991

4.  Pharmacological and toxicological properties of azelastine, a novel antiallergic agent.

Authors:  H J Zechel; N Brock; D Lenke; U Achterrath-Tuckermann
Journal:  Arzneimittelforschung       Date:  1981

5.  Azelastine effects on electrical and mechanical activities of guinea pig papillary muscles.

Authors:  P A Molyvdas; F W James; N Sperelakis
Journal:  Eur J Pharmacol       Date:  1989-05-30       Impact factor: 4.432

6.  Effect of azelastine on the release and action of leukotriene C4 and D4.

Authors:  S Katayama; H Tsunoda; Y Sakuma; H Kai; I Tanaka; K Katayama
Journal:  Int Arch Allergy Appl Immunol       Date:  1987

7.  Mechanism of inhibitory effects of azelastine on smooth muscle contraction.

Authors:  M Masuo; T Shimada; T Kitazawa
Journal:  J Pharmacol Exp Ther       Date:  1992-03       Impact factor: 4.030

8.  Blockage of the fast sodium current by dimethindene in frog auricular fibres.

Authors:  J Mészáros; R Markó; K Kelemen; V Kecskeméti
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-03       Impact factor: 3.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.